For instance, we found a higher density of tumor‐infiltrated CD8+, which is in line with previous studies, where increased amounts of CD8+, CD4+, and other immune cells in primary cutaneous melanoma correlated with prolonged survival from patients.[51, 52] However, we did not monitor survival but slight tumor reduction after oxPMEL vaccination, and we suspect that stronger effects would have been observed with longer monitoring. This evidence concerns the gene CD8A and cutaneous melanoma.